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Surgical treatment of pulmonic stenosis in dogs under cardiopulmonary bypass: outcome in 9 dogs 1 
 2 
Objectives: to describe the outcome for 9 dogs with pulmonic stenosis treated by open patch grafting using 3 
expanded polytetrafluoroethylene under cardiopulmonary bypass. 4 
Methods: data were collected from the hospital records of all dogs that had undergone right ventricular 5 
outflow tract grafting with an expanded polytetrafluoroethylene patch under cardiopulmonary bypass 6 
between 2006-2012 for the treatment of pulmonic stenosis. Echocardiographic images were reviewed and 7 
the pressure gradient across the right ventricular outflow tract re-measured. Owners for dogs still alive at 8 
the time of writing were invited to return to the hospital for reassessment.  9 
Results: 9 dogs met the inclusion criteria. Median pressure gradient pre-operatively was 118 mmHg, (range 102 10 
to 259 mmHg) reducing to a median of 20 mmHg (range 7-53 mmHg) at 48 hours post-operatively and 14 11 
mmHg (range 10 to 70 mmHg), with a median percentage reduction of 89% (range 41 to 94%) at 12 
long term follow-up. 8/9 dogs survived surgery, with 6/9 surviving to hospital discharge.  Two dogs were still 13 
alive over 6 and 8 years post-operatively. No long term deaths were believed to be attributable to pulmonic 14 
stenosis.  15 
Clinical significance: expanded polytetrafluoroethylene patch grafting of the right ventricular outflow 16 
tract for treatment of severe pulmonic stenosis in dogs is feasible and can be an effective method to reduce 17 
the severity of right ventricular outflow tract obstruction.  18 
 19 
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Introduction 29 
Pulmonic stenosis (PS) is caused by a narrowing or obstruction of the right ventricular outflow tract (RVOT) in 30 
the region of the pulmonic valve. It has been reported to be the most common congenital heart disease in dogs, 31 
accounting for 32% of congenital defects in one study (Oliveira et al. 2011) and is most frequently caused by a 32 
valvular malformation (Oliveira et al. 2011, Ristic et al. 2001)1. Balloon valvuloplasty (BV) is generally 33 
considered to be the most appropriate first line treatment for valvular PS  due to its safety and reportedly high 34 
success rates (Johnson et al. 2004a). Surgical intervention is considered in dogs in which BV has failed to reduce 35 
the pressure gradient (PG) within the RVOT, to relieve clinical signs, or in dogs considered to be poor 36 
candidates for BV. The latter include dogs with deformed, dysplastic valve leaflets (type B valvular stenosis) 37 
and hypoplasia of the pulmonic valve annulus (Bussadori et al. 2001, Locatelli et al. 2011), or those dogs in 38 
which there is significant infundibular  hypertrophy contributing to dynamic outflow tract obstruction (Johnson 39 
et al. 2004b).  For these dogs, the RVOT patching technique is considered more likely to be successful in 40 
reducing the RVOT PG (Hunt et al. 1993, Orton et al. 1990).   41 
 42 
Patch grafting of the RVOT was originally reported in the human literature for the treatment of tetralogy of 43 
Fallot in 1956 (Lillehei et al. 1956). Since then a variety of patch materials and techniques have been described, 44 
including aortic homografts (Longmore et al. 1966), autologous fascia lata composite grafts (Ionescu et al. 45 
1970), autologous pericardial patch grafts (Yang et al. 2013), cryopreserved homografts (Youn et al. 2007),  46 
polyethylene terephthalate (PET) (Breznock et al. 1976) and expanded polytetrafluoroethylene (ePTFE) 47 
(Matsumoto et al. 2001, Orton et al. 1990). Similarly there has been a wide variety of techniques reported in 48 
dogs. Initial reports in dogs describe variations of  closed pericardial patch-grafting techniques, perfomed 49 
without  the need for cardiopulmonary bypass or total venous inflow occlusion) (Breznock  et al 1976, 1976, 50 
Shores et al. 1985, Hunt et al 1993, Staudte et al 2004) .  Collectively these studies report experience from a total 51 
of 35 dogs, with a  perioperative mortality rate of 11-17%.  52 
 53 
A modified open technique has also been described using total venous inflow occlusion (TVIO) (Orton et al. 54 
1990, Hunt et al 1993), incorporating an expanded polytetrafluoroethylene patch (ePTFE) or  native pericardial 55 
patch with or without concurrent hypothermia. More recently, open patch-grafting has been described using 56 
bovine vena cava patch graft under cardiopulmonary bypass in 10 dogs  (Tanaka et al 2009) and in 2 additional 57 
dogs using glutaraldehyde-fixed canine tunica vaginalis (Fujiwara et al. 2012).  58 
 59 
Collectively, these descriptive reports present the short term results of a range of techniques and patch graft 60 
materials and document a range of follow up times, with a maximum follow-up time of 40 months. Notably 61 
many of these reports predate the time when balloon valvuloplasty became an established and widely performed 62 
procedure in dogs.  Thus only a total of 12 dogs are reported that have undergone patch graft surgery under 63 
conditions of CPB.  64 
 65 
The purpose of the study reported here was to describe the short and long term outcome for 9 consecutive dogs 66 
with pulmonic stenosis treated by open patch grafting using ePTFE under CPB, and to compare their outcomes 67 
to those previously reported in the literature using alternative techniques.   68 
 69 
Materials and Methods 70 
Cases were selected for surgery if they had a diagnosis of pulmonic stenosis and had either undergone balloon 71 
valvuloplasty without an adequate reduction in pressure gradient and/or clinical signs, or were considered at a 72 
high risk of failing an attempted balloon valvuloplasty approach, as discussed above. Owners were carefully 73 
counselled as to the emotional and financial commitment of the procedure and consented to surgery after full 74 
consideration of the risks involved. Data were collected from the medical records of all dogs that had been 75 
diagnosed with pulmonic stenosis that had undergone RVOT patching under CPB between 2006-2012. The 76 
diagnostic criteria for PS was the generation of an estimated PG in the RVOT of greater than 20mmHg, 77 
calculated from the modified Bernoulli equation, using the spectral Doppler derived peak blood flow velocity 78 
(Bussadori et al. 2000) with concurrent typical 2D lesions; the latter included the presence of pulmonic valve 79 
leaflet fusion and systolic doming, thickened or dysplastic leaflets or PA annulus hypoplasia. Dogs with 2D 80 
lesions consistent with double chambered right ventricle or infundibular PS were excluded.  Data collected 81 
included signalment, clinical signs, previous and current medication, echocardiographic data, duration of 82 
anaesthesia, duration of CPB and surgery, and pre- and post-operative complications. Long-term survival 83 
outcome was determined by contacting the referring veterinarians. For dogs still alive, the owners were 84 
contacted and asked to complete the FETCH questionnaire (Freeman et al. 2005). Owners were invited to return 85 
to our centre for re-examination and a repeat echocardiogram. Minor complications were defined as those 86 
requiring no surgical intervention and major as those requiring surgical intervention or resulting in death. 87 
 88 
Echocardiographic studies were performed by a board-certified cardiologist or supervised cardiology 89 
resident using the same ultrasound machine (Vivid 7 or Vivid E9, General Electric Medical Systems 90 
Ultrasound).  Standard echocardiographic views were obtained according to recommendations by the 91 
Echocardiography Committee of American College of Veterinary Internal Medicine (Thomas et al. 1993). 92 
Spectral Doppler tracings were also acquired to demonstrate flow across the stenosis (from either the right 93 
parasternal short axis view or left cranial view, according to the view considered to optimise alignment 94 
with the maximal flow velocity). Echocardiographic data collected included the PG within the RVOT pre-95 
balloon valvuloplasty (where applicable), pre-operative PG (PGpre), the PG 48 hour post-operatively (PG48) 96 
and the PG at the final assessment (PGfinal).  Pulmonic insufficiency was assessed and graded according to 97 
Locatelli et al. (2011); the presence and severity of pulmonary valve insufficiency  98 
pre- and post-operatively was assessed through colour flow mapping, considering the extension of the 99 
regurgitating jet and its width at the origin.
 
Any pulmonic regurgitant jet with a proximal width greater 100 
than 50% of the right ventricular outflow tract diameter at that level was considered significant. If the jet 101 
extended only into the outflow tract, the regurgitation was classified as mild. If the jet proceeded to the 102 
tricuspid valve, the regurgitation was considered severe. Between both was considered moderate (Locatelli 103 
et al. 2011). All stored images were reviewed by and re-measured by a single examiner (JS).  104 
 105 
The protocols for anaesthesia and CPB used in this study were performed as previously described (Orton et al. 106 
2001, Orton et al. 2002). All dogs had a right central venous line placed and invasive arterial blood pressure 107 
monitoring was performed via a dorsal pedal arterial catheter or if unable to obtain cannulation at this site, via a 108 
“cut down” to the right femoral artery. Perioperative antibiotic prophylaxis was with cefuroxime (Zinacef, 109 
Galxosmith Kline) at 20mg/kg intravenously, every 90 minutes. A left 5th intercostal thoracotomy was 110 
performed.  The cardiopulmonary bypass circuit consisted of either a single one-stage or two-stage venous 111 
drainage cannula placed through the right auricular appendage and into the right atrium/caudal vena cava, as 112 
appropriate.  In one dog with tricuspid valve dysplasia, bicaval cannulation was performed with one cannula 113 
placed directly into the extracardiac cranial vena cava (CVC) and the caudal caval cannula placed across the 114 
right atrium, via the right auricular appendage, with snares around the cranial and caudal cavae to create total 115 
bypass and minimise the risk of air entering the circuit across the incompetent tricuspid valve.  The arterial limb 116 
of the circuit was completed with an arterial cannula in the left external carotid. An aortic root cannula was 117 
placed through a pre-placed purse string suture of 5-0 Prolene. Following aortic cross-clamping, cold (4º C) 118 
cardioplegia solution (Cardioplegia infusion – Martindale), combined with blood from the bypass circuit, was 119 
infused into the aortic root through this cannula, in all but one dog who received no cardioplegia. Cardioplegia 120 
was delivered at 20 minute intervals or whenever mechanical cardiac muscular activity was observed. An 121 
incision was made across the valve from the main pulmonary artery extending into the ventricle, mid-way 122 
between the paraconal interventricular branch of the left coronary artery and the right coronary artery. The 123 
incision was extended two thirds of the way down the ventricular free wall towards the apex of the heart (Figure 124 
1).  The valve leaflets were examined and excised.  A sheet of ePTFE was trimmed to the appropriate size in an 125 
ovoid shape and sutured into the defect in the pulmonary artery using GoreTex® suture material (CV-5). This 126 
was placed using a double armed suture with an ePTFE pledget started at the proximal end of the patch where a 127 
knot was tied. A line of sutures was then placed in a simple continuous pattern at the caudal border, followed by 128 
the same pattern with the other end of the suture at the cranial border. These were then knotted together with 129 
addition of a second ePTFE pledget at the ventral extent of the patch (Figure 2). The hearts were de-aired as the 130 
last sutures were placed in the patch. The dogs were re-warmed, the cross clamp removed and the dogs were 131 
weaned from CPB once normal sinus rhythm or a regular epicardial paced rhythm was established.  The dogs 132 
were recovered from anaesthesia in the intensive care unit where their therapy was adjusted according to 133 
perceived needs based on changes in arterial blood gas measurements, blood pressure, urine production and fluid 134 
retrieved from the chest drain.  Antiplatelet therapy (aspirin 0.5mg/kg PO q24 h) was instituted the day 135 
following surgery and continued for three months. 136 
 137 
Statistical analysis was performed using a commercially available software package (GraphPad Prism 6). 138 
Descriptive statistics were performed and reported as median and range if not normally distributed and 139 
mean and standard deviation if normally distributed. Continuous data (PG, weight, age, time of 140 
anaesthesia, bypass and surgery) were assessed for normality using the Shapiro-Wilk Test.  141 
 142 
Results 143 
Nine dogs met the inclusion criteria. There were two Cocker spaniels and one each of Japanese Akita, 144 
Bullmastiff, English Bulldog, Flat coated retriever, German Shepherd dog,  Miniature Schnauzer and 145 
Shetland Sheepdog. Seven dogs were male (four entire) and two were female entire. Body weight at time 146 
of surgery ranged from 7 to 43.6 kg with three dogs weighing 15 kg or under. Age at the time of surgery 147 
ranged from 7 to 38 months with 6 dogs less than one year old, (Table 1).  148 
 149 
Pre-operative data 150 
All dogs apart from one underwent balloon valvuloplasty prior to surgery. The 8 month old Shetland 151 
Sheepdog did not undergo balloon valvuloplasty as she had severe infundibular hypertrophy and a very 152 
hypoplastic pulmonary artery (with a main pulmonary artery:aortic diameter ratio of 1:2.35 and no 153 
evidence of post-stenotic dilation), and the  chances of success with BV were considered to be low. Time 154 
from BV to surgery ranged from 56 to 454 days with a mean of 126 ± 57 days. The pre-balloon 155 
valvuloplasty PG was available for 5 dogs and consistent with severe stenosis in all, with a median value of 156 
164 mmHg (range 127-210 mmHg). After balloon valvuloplasty the median PG was 113 mmHg (range 157 
108-167 mmHg).  158 
 159 
Five dogs had clinical signs attributed to their cardiac disease pre-operatively; 2 had exercise intolerance, 160 
one had a history of syncope, one was exercise intolerant and inappetent and another was polycythaemic 161 
and cyanotic. Two dogs had experienced episodes of right sided congestive heart failure pre-operatively. 162 
All dogs were receiving cardiac medications that included atenolol in all dogs (Teva, Tenormin; 163 
AstraZeneca), furosemide (Frusedale; Dechra, Frusemid; Millpledge, Frusol; Rosemont), n=3, benazepril 164 
(Fortekor; Elanco Animal Health or Benazecare; Animal Care Group plc), n=3 and spironolactone 165 
(Prilactone; Ceva), n=2. Three dogs were receiving 3 medications with the remainder receiving one 166 
(atenolol).  167 
 168 
On echocardiography, 4 dogs had a patent foramen ovale (PFO), 3 of which were right to left shunting (the 169 
direction of shunting was not confirmed retrospectively in one dog due to the lack of a bubble study). One 170 
dog had a small (1.5mm) sub-aortic ventricular septal defect (VSD) with right to left systolic shunting (this 171 
was the dog with severe infundibular hypertrophy and a very hypoplastic pulmonary artery). As well as 172 
having a PFO, one dog also had tricuspid valve dysplasia, characterised by abnormal tethering of both 173 
valve leaflets and the presence of tricuspid regurgitation. Tricuspid regurgitation was estimated to be 174 
severe based on a subjective assessment of the size of the tricuspid regurgitation jet in relation to the size 175 
of the right atrium.  Median PGpre was 118 mmHg, (range 102 to 259 mmHg). Pulmonic regurgitation was 176 
able to be assessed in 4 dogs pre-operatively and was graded as moderate in 3 and as mild in 1.  177 
 178 
Intra-operative data 179 
Surgery was performed under CPB in all dogs, with one performed with the heart beating. In addition to patch 180 
grafting of the RVOT, all dogs had partial/subtotal pulmonic valvectomy.   181 
 182 
Intraoperative complications occurred in two dogs. One dog was euthanatised intra-operatively due to inability 183 
to successfully wean from cardiopulmonary bypass; this dog had severe hypocalcaemia but the reason it could 184 
not be weaned from bypass remains speculative. In the other dog, haemorrhage from the aortic root cannulation 185 
site occurred and this was repaired with sutures. 186 
 187 
Eight out of 9 dogs survived surgery.  Median total anaesthesia time (n=6) was 404 minutes (range 294 to 531 188 
minutes), median surgical time (n=6) was 273 minutes (range 180 to 366 minutes), and median CPB time (n=6) 189 
71 minutes (range 27 to 168 minutes). 190 
 191 
Short term post-operative data 192 
 193 
Complications 194 
Fatal complications in the immediate post-operative period occurred in 2/8 dogs. The dog that had bled intra-195 
operatively from the aortic root cannula site developed haemothorax within a few hours of cessation of 196 
cardiopulmonary bypass, and during thoracocentesis the dog underwent cardiopulmonary arrest and died. One 197 
dog developed profound hypotension of undetermined cause and despite aggressive supportive care, suffered a 198 
fatal cardiac arrest. For the remaining dogs, median PG at 48 hours post-operatively (PG48) was 20 mmHg 199 
(range 7-53 mmHg). Pulmonic regurgitation had increased to severe in 2 dogs, remained as moderate in 1 and 200 
was graded as moderate and severe in 2 further dogs who had no pre-operative measurement of pulmonic 201 
regurgitation. 202 
 203 
Three dogs experienced complications in the peri-operative period, none of which were fatal. One dog collapsed 204 
7 days post-operatively and developed severe pyrexia with multiple joint effusions and joint pain. Investigations 205 
revealed elevations in liver enzyme activity and hyperbilirubinaemia, in addition to thrombocytopaenia, anaemia 206 
and prolongation of clotting times. This dog recovered with supportive care including fluid therapy and 207 
analgesia. A further dog developed hypoxia 4 days post-operatively. Radiographic evidence of an alveolar 208 
pattern was present and the dog recovered with supportive care (oxygen supplementation and antibiosis). One 209 
dog developed pleural and peritoneal effusions 72 hours post-operatively that resolved following diuretic 210 
treatment. Therefore, six out of 9 dogs survived to discharge.    211 
 212 
Medium to long-term post-operative data 213 
 214 
Echocardiographic data 215 
Medium to long-term post-operative data was available for all surviving dogs. Median time from surgery to last 216 
echocardiographic exam was 1977 days (range 429 to 3098 days). The PG at final echocardiographic 217 
examination (PGfinal) was below 20mmHg in 62.5% of dogs (5/8). The median PGfinal was 14 mmHg (range 10 to 218 
70 mmHg), with a median percentage PG reduction of 89% (range 41 to 94%), (Figure 3).  No dogs were 219 
receiving cardiac medications at their final assessment.  220 
 221 
Survival data 222 
None of the dogs that survived to discharge were believed to experience a death related to PS. At the time of 223 
writing 2 dogs were still alive at 6 years 9 months (Cocker Spaniel) and 8 years 7 months (German Shepherd) 224 
post-operatively. Both dogs returned to our clinic for re-examination. At re-examination both dogs had normal 225 
exercise tolerance and were considered well by their owners, with FETCH scores of 7/90 and 3/90 respectively 226 
(higher scores indicate poorer quality of life). Pressure gradients across the RVOT were 35 mmHg and 14 227 
mmHg respectively.  228 
 229 
In three dogs that had died, the cause of death was one each: systemic mast cell disease (5 years post-230 
operatively), osteosarcoma (7 years post-operatively) and severe pancreatitis resulting in acute respiratory 231 
distress syndrome (5 years 2 months post-operatively). One dog died with right heart failure 5 years post-232 
operatively, believed to be associated with concurrent tricuspid dysplasia. This was the dog diagnosed with 233 
tricuspid valve dysplasia prior to patch grafting and his PG had decreased from 113 mmHg pre-operatively to 14 234 
mmHg at the date of his last examination (429 days post-operatively).  235 
 236 
Discussion 237 
 238 
The data reported here comprises the largest number of dogs treated using an ePTFE graft under conditions of 239 
CPB, and has the longest follow-up to date. In this population of dogs, ePTFE patch grafting of the RVOT under 240 
CPB for treatment of severe PS was associated with a significant and sustained reduction in the RVOT PG and 241 
excellent long-term survival in dogs surviving the peri-operative period. Although we were not able to obtain 242 
final assessment echocardiograms from all dogs that survived to discharge, only one dog’s death was related to 243 
heart disease. This dog was evaluated by us with his death considered to be associated with the dogs pre-existing 244 
tricuspid valve dysplasia since his pulmonic valve PG remained low at 14 mmHg and apart from the tricuspid 245 
valve changes there were no other structural abnormalities in the heart.  The PG remained markedly reduced in 246 
all dogs at the time of their final echocardiographic assessment and no evidence of sub-clinical restenosis was 247 
seen, further demonstrating the durability of this technique.  Interestingly, two dogs had a PG of over 50 mmHg 248 
which has been described above the limit for an optimal outcome (Locatelli et al. 2011), post-operatively yet still 249 
had an excellent long term outcome. One dog had a PG of 70mmHg. We conclude, therefore, that this technique 250 
gave sustained long term resolution of PS-related signs in those dogs that survived to discharge.  251 
 252 
In the study reported here, one intraoperative fatality occurred and two dogs died in the immediate postoperative 253 
period. The exact cause of death for these dogs is not clear although it is most likely one dog had fatal post-254 
operative intrathoracic haemorrhage. Because post mortem examination was not permitted, this cannot be 255 
confirmed. The intraoperative death was associated with failure to successfully wean the dog from CPB. 256 
Possible causes for this include myocardial ischaemia secondary to poor myocardial perfusion/protection with 257 
cardioplegia, myocardial hypoperfusion (of the very thick right ventricle), coronary artery air embolization or 258 
coronary artery obstruction by blood clot formation; all of which might prove difficult to confirm definitively 259 
even with post-mortem examination. This dog’s sustained hypocalcaemia may also have been a factor. 260 
 261 
None of the previous reports are exactly alike in terms of patient selection criteria or surgical technique used. 262 
The main technical differences are between the use of a closed technique without total venous inflow occlusion 263 
(n=2) (Shores et al. 1985, Staudte et al. 2004), closed or modified open technique with TVIO (n=2) (Hunt et al. 264 
1993, Orton et al. 1990), or an open technique under  CPB (n=2) (Fujiwara et al. 2012, Tanaka et al. 2009). 265 
There are a variety of reasons for each institution having reported the use of different techniques including 266 
experience, cost, and availability of specialised equipment, such as that required to operate under CPB. The two 267 
most recent reports use CPB, perhaps reflecting the increasing availability of this equipment and expertise, and 268 
the success reported with its use for other conditions (Fujiwara et al. 2012,  Mizuno et al. 2012, Orton et al. 269 
2005, Uechi et al. 2012). In human patients that require surgical correction of PS caused by valve annulus 270 
hypoplasia and fibrous valvular malformation (analogous to type B morphology in dogs), an open approach 271 
under CPB is the standard of care, rather than surgery under TVIO, for reasons of safety, control and surgical 272 
accuracy.  Our reasons for using CPB were multifactorial: firstly, as previously mentioned, this is considered 273 
preferable for surgical treatment of similar PS in humans. Secondly, use of CPB allows sufficient time to open 274 
the heart and fully evaluate the source of obstruction and the pulmonic valve, thereby allowing the surgeon to 275 
assess and accurately resect tissue likely to contribute to on-going obstruction. In addition, it allows accurate 276 
sizing and suturing of an ePTFE patch so as to reconstruct the outflow tract in a way that minimizes risk of 277 
residual or subsequent obstruction. Finally, we had already started using CPB for treatment of other surgical 278 
conditions at our institution and therefore had some experience with the technique. In contrast, TVIO allows 279 
only limited time to visualise and address abnormalities of the valve complex and so is described to facilitate 280 
either “closed” or “semi open” valvotomy. These techniques are arguably more suited to dogs with fused valve 281 
leaflets (type A) rather than type B PS. That is; a morphology of PS that would respond well to the much safer 282 
BVP approach. It is difficult to make meaningful comparisons between the use of CPB and TVIO for surgical 283 
treatment of PS in dogs given the small number of reports and low case numbers. Comparisons of mortality rate 284 
are somewhat similar with 4/4 dogs surviving surgery in Orton et al.’s report with TVIO (1990), and 7/8 285 
surviving in Hunt et al.’s (1993), (Hunt et al. 1993, Orton et al. 1990). Similarly with the use of a closed 286 
technique, 8/9 survived (Staudte et al. 2004; Shores et al. 1985). With use of CPB 8/10 dogs survived surgery in 287 
one report (Tanaka et al. 2009) and 8/9 dogs in a further report (Fujiwara et al. 2012), which is comparable to 288 
our surgical survival rate of 8/9 dogs. In order to compare techniques in a meaningful way, a prospective 289 
comparison of a larger number of dogs with similar disease status and selected for surgical intervention using 290 
standard criteria, and with a long follow up time, would be needed.  291 
 292 
As mentioned above, one advantage of the use of CPB is the increased time afforded to analyse and address the 293 
cause(s) of the stenosis. This operation does, however create almost complete pulmonic valvular incompetence.  294 
Pulmonic valvular incompetence is reported as a late (30 years after surgery) complication in humans that 295 
undergo complete repair of tetralogy of Fallot (Therrien et al. 2000). This has led some surgeons to recommend 296 
pulmonic valve replacement in this group of patients.  The study reported here would suggest that pulmonic 297 
valvular incompetence is well tolerated in this canine population; we accept that this is a small number of dogs 298 
with limited follow-up, however in all dogs there was moderate to severe pulmonic insufficiency at the final 299 
examination but this was not associated with long term clinically significant adverse remodelling, ventricular 300 
arrhythmia or CHF. One dog did develop right sided CHF but this was the dog with tricuspid valve dysplasia.  301 
 It is possible that a complication that takes 30 or so years to develop in a human might not be a concern in the 302 
context of a canine lifespan.   303 
 304 
None of the dogs in our report died from heart disease directly related to their PS and both dogs with right sided 305 
heart failure pre-operatively had resolution of this. However one dog died of heart failure six months post-306 
operatively in Hunt et al.’s study (1993) of patching under TVIO; and in Staudte et al.’s report of a closed 307 
technique with use of a valvulotomy-ventriculotomy wire one dog died of heart failure at 16 months post-308 
operatively (Hunt et al. 1993, Staudte et al. 2004). In this latter report (Staudte et al. 2004), three dogs also 309 
experienced syncopal episodes upon extreme exertion or exercise after surgery, whereas all dogs in the study 310 
reported here remained free of clinical signs relating to PS (although, as mentioned, one dog did develop heart 311 
failure secondary to TVD five years after surgery). The fact that previous reports of surgical treatment of PS 312 
only contain relatively short term follow up mean that it is possible that recurrence of signs is an under reported 313 
complication. Without larger patient numbers and a carefully controlled prospective study, it is impossible to 314 
draw comparisons as to which technique may be superior.  315 
 316 
Another difference in techniques to date is the use of differing materials for the patch with ePTFE, native 317 
pericardium, bovine vena cava patch graft and glutaraldehyde fixed canine tunica vaginalis all previously 318 
reported. Expanded polytetrafluoroethylene sheets are sterile “medical grade”, “off the shelf” products with no 319 
known adverse health and safety side effects for user or recipient.  It is easy to handle and can be cut to size, as 320 
needed.  Because of the potential harmful effects of glutaraldehyde and the lack of availability of all natural 321 
products other than native pericardium, and the fact that ePTFE had been previously described for this use, we 322 
chose this in our dogs.  323 
 324 
As in other reports of PS, some of our dogs had concurrent congenital cardiac abnormalities; VSD in one dog, 325 
PFO in four dogs and TVD in one. The VSD was only 1.5 mm in diameter and in the subaortic position. 326 
Surgical exposure of all of these defects would have been best achieved through a right atriotomy rather than the 327 
right ventriculotomy incision required for the RVOT patch.  The decision not to address the PFOs surgically was 328 
based on the assumption that if the RVOT patch achieved the anticipated change in RV pressure, this would, in 329 
turn reduce right atrial pressure to a level that would no longer favour right to left shunting of blood across the 330 
PFO. This assumption was proved to be correct on follow-up echocardiography in one dog that had right to left 331 
shunting prior to patching.  We were not able to perform a bubble study at long term follow up to confirm the 332 
absence of shunting in the second dog but one dog there was still evidence of right to left shunting on cardiac 333 
echo. This dog, however, did not show any clinical signs associated with right to left shunting of blood.  The 334 
decision not to treat the TVD surgically in the dog with concurrent PS and TVD, was also based on the 335 
presumption that the tricuspid regurgitation secondary to TVD would reduce once the PS had been treated as 336 
well as the fact that there was no tried and tested surgical therapy for TVD at that time.  Finally, the decision not 337 
to surgically manage the VSD in the two dogs that had this lesion was based on the small size of the VSD and 338 
the assumption that these would only have minor haemodynamic significance, once the PS had been treated. In 339 
addition, they were relatively inaccessibile via the right ventriculotomy. Again, this assumption proved to be 340 
correct based on follow up echo studies and the long term survival.  Indeed, only one dog developed clinical 341 
signs relating to the concurrent cardiac abnormality (TVD) and this ultimately resulted in the death of the dog 5 342 
years after surgery for PS. This dog still enjoyed a sustained period of a good quality of life following PS 343 
surgery.  344 
 345 
Based on our results, ePTFE patch grafting of the RVOT is an effective and durable treatment for severe PS, in 346 
dogs that have failed BV. Whether it can also be an effective treatment for dogs who are not considered good 347 
candidates for BV due to their concurrent congenital malformations remains to be seen.  348 
The peri-operative mortality rate can be high but if dogs survive the peri-operative period then a significant 349 
reduction in pressure gradient can be achieved with an excellent long-term prognosis. It is important to 350 
recognize that the dogs reported here, along with a group of 9 dogs that underwent tricuspid valve replacement 351 
and 3 dogs that underwent patching for double chambered right ventricle, represent the first 21 dogs operated on 352 
by the bypass team at our institution and as such, represent the beginning of the “learning curve”. It is 353 
anticipated, therefore, that further familiarity with these operative techniques, and refinements in patient 354 
selection criteria, anaesthetic care and post-operative requirements, will result in significant reduction in short 355 
term mortality and therefore improve overall outcome, as shown by another team with vast experience (Uechi et 356 
al. 2012). Based on the small number of dogs reported here, open patch grafting under cardiopulmonary bypass 357 
is feasible and results in durable reduction in PG along with long term relief from the clinical signs of PS, 358 
providing the tricuspid valve function is good. 359 
 360 
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